Ventripoint

Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) will be supporting a world-first study on maternal cardiovascular changes during pregnancy, which will be conducted at the Mazankowski Alberta Heart Institute in Edmonton, Alberta, Canada.Dr. Lisa Hornberger, Principal Investigator of…...

Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is pleased to announce that they will be a sponsor for the 24th Annual CSE Echo Weekend. The conference will be held digitally February 4th-6th 2022 and will have the feature…...

Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is pleased to announce that is it has successfully completed a surveillance audit of its quality assurance system under Medical Device Directive 93/42/EEC (MDD), Annex II with no findings. This is…...

Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is pleased to announce the Company has received official notification from OTC Markets to up-list to the OTCQB tier effective as of January 7, 2022. The Company will trade on the…...

Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is pleased to announce that is it has successfully completed the Medical Device Single Audit Program (MDSAP)re-certification for its Quality Management System (QMS) under ISO 13485:2016 regulations and the FDA Quality…...

Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that Randy AuCoin has joined the Ventripoint Board of Directors.“We are thrilled to have Randy AuCoin join the Board of Directors and utilize his extensive experience in…...

Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) is pleased to announce that Ventripoint has received additional advisory services and up to $107,000 in research and development funding from the National Research Council of Canada Industrial Research Assistance Program…...

Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased that the U.S. Department of Health and Human Services (HHS) through CMS (Centers for Medicare & Medicaid Services) has approved a new compensation for doctors to analyze 3D echocardiograms.“3D…...

Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that Ventripoint will be highlighted as one of Life Sciences Ontario (LSO) 2021 Success Stories (https://lifesciencesontario.ca/reports-and-publications/). The LSO campaign aims to highlight companies and institutions that are…...

Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that they have successfully completed a semi-annual follow up inspection of their manufacturing facility by a Nationally Recognized Testing Laboratory (NRTL).A NRTL test mark reflects a manufacturer’s…...